Dongwon Industries Enters Bio Industry... Moves to Acquire Boryung Biopharma
Dongwon Industries is making a full-scale entry into the pharmaceutical and biotechnology industry by acquiring Boryung Biopharma.
On the 23rd, Dongwon Industries announced through a public disclosure that it had signed a memorandum of understanding with Boryung Partners regarding the acquisition of Boryung Biopharma. Dongwon Industries plans to conduct due diligence on Boryung Biopharma independently. Based on the results, it has secured exclusive priority negotiation rights.
Boryung Biopharma, established in 1991, is a biotechnology company engaged in the development of technologies such as vaccines and genomic diagnostics.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "I Will Give Them a Chance for Self-Examination": Chinese Scientific Community Shaken by Influencer's Preemptive Whistleblowing
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Last month, Dongwon Industries also participated solely in the preliminary bidding for the sale of McDonald's Korea. It is reported that Dongwon Industries is conducting due diligence and is preparing for full-scale price negotiations.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.